| [1] |
周代会，唐怡. 肾移植患者HCV感染的临床治疗研究进展[J]. 肝脏，2018, 23(8)：730-733.
|
| [2] |
Fabrizi F, Martin P, Dixit V, et al. Hepatitis C virus antibody and survival after renal transplantation: meta analysis of observational studies[J]. Am J Transplant, 2005, 5(6)：1452-1461.
|
| [3] |
Fernandes AR, Laranjinha IJ, Birne R, et al. HCV-infected renal transplant recipients：our experience before the availability of new antiviral drugs[J]. Int J Organ Transplant Med, 2017, 8(2)：104-109.
|
| [4] |
刘航，史屹，沈中阳. 肾移植术后新发糖尿病的危险因素及其对动脉僵硬度的影响[J]. 中华器官移植杂志，2009, 30(7)：415-418.
|
| [5] |
Khalili M, Lim WJ, Bass N, et al. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection[J]. Liver Transpl, 2004, 10(3): 349-355.
|
| [6] |
王红英. 关于丙肝病毒感染并发2型糖尿病的临床研究[J]. 心血管病防治知识(学术版), 2014, (2)：136-138.
|
| [7] |
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology(MOOSE)group[J]. JAMA, 2000, 283(15)：2008-2012.
|
| [8] |
Panesar SS, Athanasiou T, Nair S, et al. Early outcomes in the elderly: a meta- analysis of 4921 patients undergoing coronary artery bypass grafting-comparison between off-pump and on-pump techniques[J]. Heart, 2006, 92(12)：1808-1816.
|
| [9] |
Athanasiou T, Al-Ruzzeh S, Kumar P, et al. Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients[J]. Ann Thorac Surg, 2004, 77(2)：745-753.
|
| [10] |
Bloom RD, Sayer G, Fa K, et al. Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list[J]. Am J Transplant, 2005, 5(1): 139-144.
|
| [11] |
Yildiz A, Tutuncu Y, Yazici H, et al. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients[J]. Transplantation, 2002, 74(8)：1109-1113.
|
| [12] |
Gursoy M, Guvener N, Koksal R, et al. Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients[J]. Transplant Proc, 2000, 32(3): 561-562.
|
| [13] |
Gentil MA, Luna E, Rodriguez-Algarra G, et al. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C[J]. Nephrol Dial Transplant, 2002, 17(5)：887-891.
|
| [14] |
Sens YAS, Silva VDST, Malafronte P, et al. Post-transplant diabetes mellitus in renal transplant patients with hepatitis C virus[J]. Transplant Proc, 2004, 36(4)：886-888.
|
| [15] |
Foo SM, Wong HS, Morad Z. Risk factors and incidence of posttransplant diabetes mellitus in renal transplant recipients[J]. Transplant Proc, 2004, 36(7)：2139-2140.
|
| [16] |
Gourishankar S, Jhangri GS, Tonelli M, et al. Development of diabetes mellitus following kidney transplantation: a Canadian experience[J]. Am J Transplant, 2004, 4(11)：1876-1882.
|
| [17] |
陈敏灵，张尧，于明香，等. 肾移植术后糖尿病的发病及其危险因素分析[J]. 中华内分泌代谢杂志，2013, 29(9)：750-755.
|
| [18] |
王英吉，狄文佳，孙勤，等. 肾移植术后糖尿病相关危险因素[J]. 肾脏病与透析肾移植杂志，2015, 24(1)：21-25.
|
| [19] |
Sezer S, Bilgic A, Uyar M, et al. Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients[J]. Transplant Proc, 2006, 38(2)：529-532.
|
| [20] |
Schnitzler M, Kasiske BL, Snyder JJ, et al. Diabetes mellitus after kidney transplantation in the United States [1] (multiple letters)[J]. Am J Transplant, 2003, 3(10)：1318-1319.
|
| [21] |
Rodrigo E, De Cos MA, Fernández-Fresnedo G, et al. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus[J]. Transplant Proc, 2005, 37(9)：3819-3820.
|
| [22] |
Baid S, Tolkoff-Rubin N, Farrell ML, et al. Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: Role of hepatitis C infection[J]. Transplant Proc, 2002, 34(5)：1771-1773.
|
| [23] |
Gentil MA, López M, González-Roncero F, et al. Hepatitis C and the incidence of diabetes mellitus after renal transplant: Influence of new immunosuppression protocols[J]. Transplant Proc, 2003, 35(5)：1748-1750.
|
| [24] |
Kamar N, Mariat C, Delahousse M, et al. Diabetes mellitus after kidney transplantation: A French multicentre observational study[J]. Nephrol Dial Transplant, 2007, 22(7)：1986-1993.
|
| [25] |
López Hidalgo R, Gentil MA, Acosta D, et al. Asociación entre diabetes mellitus y hepatitis C en trasplante renal[J]. Nefrologia, 2004, 24(6)：572-578.
|
| [26] |
Guleria S, Kamboj M, Chatterjee A, et al. Generic tacrolimus (Pan Graf) in renal transplantation: An experience of 155 recipients in India[J]. Transplant Proc, 2008, 40(7)：2237-2239.
|
| [27] |
Hirakauva EY, Ferraz MLG, Perez RM, et al. Prevalence of diabetes mellitus in renal transplant patients with hepatitis B or C virus infection[J]. Transplant Proc, 2002, 34(8)：3220-3222.
|
| [28] |
Liang J, Lv C, Chen M, et al. Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new-onset diabetes after kidney transplantation[J]. J Diabetes, 2019, 11(5)：370-378.
|
| [29] |
Santos AH, Chen C, Casey MJ, et al. New-onset diabetes after kidney transplantation: Can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology？[J]. Nephrol Dial Transplant, 2018, 33(1)：177-184.
|
| [30] |
Shah T, Kasravi A, Huang E, et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation[J]. Transplantation, 2006, 82(12)：1673-1676.
|
| [31] |
Miller J, Mendez R, Pirsch JD, et al. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group[J]. Transplantation, 2000, 69(5)：875-880.
|
| [32] |
Ahsan N, Johnson C, Gonwa T, et al. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years[J]. Transplantation, 2001, 72(2): 245-250.
|
| [33] |
Margreiter A. A prospective, randomized multicentre study to compare the efficacy and safety of tacrolimus and cyclosporin microemulsion in renal transplantation[J]. Transplantation, 69(Suppl 8)：S112-S113.
|
| [34] |
Xie L, Tang W, Wang X, et al. Pretransplantation risk factors associated with new-onset diabetes after living-donor kidney transplantation[J]. Transplant Proc, 2016, 48(10)：3299-3302.
|
| [35] |
Gentil MA, Lopez M, Gonzalez-Roncero F, et al. Hepatitis C and the incidence of diabetes mellitus after renal transplant: influence of new immunosuppression protocols[J]. Transplant Proc, 2003, 35(5)：1748-1750.
|
| [36] |
杨进，方芳，杨富，等. 肾移植术后新发糖尿病：危险因素的回顾性分析[J]. 中国组织工程研究，2017, 21(20)：3275-3280.
|
| [37] |
Siraj ES, Abacan C, Chinnappa P, et al. Risk factors and outcomes associated with posttransplant diabetes mellitus in kidney transplant recipients[J]. Transplant Proc, 2010, 42(5)：1685-1689.
|
| [38] |
Hjelmesæth J, Hartmann A, Kofstad J, et al. Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance[J]. Nephrol Dial Transplantation, 2001, 16(4)：829-835.
|
| [39] |
Bergrem HA, Valderhaag TG, Hartmann A, et al. Glucose tolerance before and after renal transplantation[J]. Nephrol Dial Transplant, 2010, 25(3)：985-992.
|
| [40] |
Maldonado F, Tapia G, Ardiles L. Early hyperglycemia: a risk factor for posttransplant diabetes mellitus among renal transplant recipients[J]. Transplant Proc, 2009, 4l(6)：2664-2667.
|
| [41] |
Kaplan NM, Palmer BF, Mora PF. Post-transplantation diabetes mellitus[J]. Am J Med Sci, 2005, 329(2)：86-94.
|
| [42] |
Kurzawski M, Dziewanowski K, Droździk M. Analysis of type 2 diabetes mellitus genetic risk factors in relation to new onset diabetes after transplantation in renal transplant recipients medicated with tacrolimus[J]. Pharmacological Reports Pr, 2013, 65(1)：1-11.
|